Nevertheless, mutations affecting Activin/Nodal signaling are frequent in cancer stem cells (CSCs) in a variety of tissues43–45, suggesting a broader role of activins in regulating SC fate decisions in adult tissues. This evidence concerns the gene INHBE and cancer.